Lactose (India) Limited (BOM:524202)

Market Cap	1.47B +8.3%
Revenue (ttm)	1.45B +23.1%
Net Income	48.28M -30.2%
EPS	3.85 -29.9%
Shares Out	12.59M
PE Ratio	30.40
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,997
Average Volume	8,044
Open	117.80
Previous Close	119.35
Day's Range	117.00 - 121.90
52-Week Range	76.01 - 136.70
Beta	0.65
RSI	63.28
Earnings Date	May 30, 2026

About Lactose (India)

Lactose (India) Limited engages in the manufacture and trading of pharmaceutical products in India and internationally. The company offers lactose monohydrate; solid dosage forms comprising dry granulated, film, and lacquer coated tablets, as well as uncoated and blister packed solid dose forms; and liquid dosage forms. It also provides disaccharide lactulose, an active pharmaceutical ingredient that is used in the treatment of constipation, hepatitis, encephalopathy, intestinal microflora, dental care, diabetes, and chronic liver disease, as w...

• Industry: Pharmaceutical Preparations
• Founded: 1991
• Employees: 140
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524202

Financial Performance

In fiscal year 2025, Lactose (India)'s revenue was 1.16 billion, an increase of 2.20% compared to the previous year's 1.14 billion. Earnings were 51.63 million, a decrease of -23.95%.